Freedom251 › AI Drug Discovery Software
C4X Discovery Taxonomy3
Facts from C4X Discovery Taxonomy3's own pages
- Clinical-trial application
- PatientSeek is described as supporting clinical-trial design and companion diagnostics. · c4xdiscovery.com, 14 Nov 2026
- Collaboration
- C4X Discovery describes a Taxonomy3 collaboration with the GEN-COVID Consortium in Italy to examine COVID-19 genetics. · c4xdiscovery.com, 14 Nov 2026
- Commercial model
- C4X Discovery says its business model includes pre-clinical licensing deals with pharmaceutical companies. · c4xdiscovery.com, 14 Nov 2026
- Drug discovery use
- The company says Taxonomy3-derived targets can inform drug discovery and biomarker identification. · c4xdiscovery.com, 14 Nov 2026
- Genetic analysis
- Taxonomy3 uses mathematical analysis of genetic data to identify disease-causing targets. · c4xdiscovery.com, 14 Nov 2026
- Headquarters
- Leeds, United Kingdom · c4xdiscovery.com, 21 Oct 2026
- Omics inputs
- PatientSeek uses genetics and other omics analyses to stratify patients. · c4xdiscovery.com, 14 Nov 2026
- Partnership contact
- The company invites inquiries about strategic collaboration and technology partnership opportunities. · c4xdiscovery.com, 14 Nov 2026
- Patient stratification
- PatientSeek is a patient-stratification platform powered by Taxonomy3. · c4xdiscovery.com, 14 Nov 2026
- Product positioning
- C4X Discovery describes itself as a drug discovery company focused on small-molecule medicines for immuno-inflammatory diseases. · c4xdiscovery.com, 14 Nov 2026
- Registered office
- C4X Discovery lists its registered office in Leeds, United Kingdom. · c4xdiscovery.com, 14 Nov 2026
- Taxonomy3 platform
- Taxonomy3 is a target-identification platform based on human genetics. · c4xdiscovery.com, 14 Nov 2026
Where C4X Discovery Taxonomy3 stands on Freedom251
- AI Drug Discovery Software#11 of 33